Streetbeat News

Analyst Ratings

CLMT

Goldman Sachs analyst Neil Mehta maintains a Buy rating on Calumet Specialty Prods (NASDAQ:CLMT) and lowers the price target from $20 to $19.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 12:29 pm

ORCL

Guggenheim analyst John Difucci maintains a Buy rating on Oracle (NYSE:ORCL) and raises the price target from $120 to $150.

Portfolio Pulse from richadhand@benzinga.com

June 13, 2023 | 12:23 pm

NDAQ

UBS analyst Alex Kramm maintains a Neutral rating on Nasdaq (NASDAQ:NDAQ) and lowers the price target from $62 to $56.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 12:22 pm

DUK

BMO Capital analyst James Thalacker maintains an Outperform rating on Duke Energy (NYSE:DUK) but lowers the price target from $109 to $102.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 12:22 pm

NFLX

Guggenheim analyst Michael Morris maintains a Buy rating on Netflix (NASDAQ:NFLX) and raises the price target from $375 to $500.

Portfolio Pulse from richadhand@benzinga.com

June 13, 2023 | 12:21 pm

CTLT

UBS analyst John Sourbeer maintains a Buy rating on Catalent (NYSE:CTLT) but lowers the price target from $60 to $55.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 12:21 pm

SHW

BMO Capital analyst John McNulty maintains a Market Perform rating on Sherwin-Williams (NYSE:SHW) and raises the price target from $253 to $269.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 12:20 pm

COGT

Guggenheim analyst Charles Zhu reiterates a Buy rating on Cogent Biosciences (NASDAQ:COGT) and maintains a $26 price target.

Portfolio Pulse from richadhand@benzinga.com

June 13, 2023 | 12:20 pm